ACA
CNTA

Avoro Capital Advisors’s Centessa Pharmaceuticals CNTA Stock Holding History

Avoro Capital Advisors’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$454M Sell
11,430,455
-3,125,100
-21% -$79.9M 4.47% 9
2025
Q4 		$364M Buy
14,555,555
+3,747,475
+35% +$94.9M 3.58% 10
2025
Q3 		$262M Buy
10,808,080
+5,808,080
+116% +$103M 3.39% 11
2025
Q2 		$65.7M Buy
5,000,000
+950,000
+23% +$12M 1.15% 20
2025
Q1 		$58.2M Buy
+4,050,000
New +$66.3M 0.91% 22
2021
Q3 		– Sell
-500,000
Closed -$11.1M – 50
2021
Q2 		$11.1M Buy
+500,000
New +$11.8M 0.19% 41

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Avoro Capital Advisors's CNTA Position: Q1 2026 in Review

Avoro Capital Advisors reduced its Centessa Pharmaceuticals (CNTA) stake by 21% in Q1 2026, selling an estimated $79.9M and leaving 11,430,455 shares worth $454M. The position accounts for 4.47% of the portfolio, ranked #9.

Avoro Capital Advisors first reported a position in CNTA in Q2 2021 and has held it in 6 quarters since. 161 funds tracked by Wall St. Rank hold CNTA as of Q1 2026.

  • Avoro Capital Advisors held 11,430,455 shares of Centessa Pharmaceuticals worth $454M as of Q1 2026.
  • Avoro Capital Advisors sold 3,125,100 Centessa Pharmaceuticals shares in Q1 2026, an estimated $79.9M.
  • Centessa Pharmaceuticals made up 4.47% of Avoro Capital Advisors's portfolio in Q1 2026, its #9 holding.
  • Avoro Capital Advisors first reported a position in Centessa Pharmaceuticals in Q2 2021 and has held it in 6 quarters since.
  • 161 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q1 2026.

Based on Avoro Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.